Phathom Pharmaceuticals (NASDAQ: PHAT) Holds Steady Pace a Month After IPO

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) has been on an uptrend since it went public in October. This follows a series of financial and technical news...

Innate Pharma S.A (NASDAQ: IPHA) Certified a Great Place to Work by an Independent...

Innate Pharma S.A (NASDAQ: IPHA) has been gaining traction since it went public in September. The company has also made a number of positive announcements...

Springworks Therapeutics (NASDAQ: SWTX) Boosted by Progress in Initial Phase of 2b ReNeu Clinical...

Springworks Therapeutics Inc (NASDAQ: SWTX) has gained significantly since it went public at an offer price of $18 in September. As of yesterday’s close, the...

IGM Biosciences (NASDAQ: IGMS) to Present at Piper Jaffray 31st Annual Healthcare Conference in...

IGM Biosciences Inc (NASDAQ: IGMS) is still up when compared to its listing price in September. Its gains have been anchored on a series of positive...

Datadog Inc (NASDAQ: DDOG) Maintains Impressive Run Post-IPO

Datadog Inc (NASDAQ: DDOG) has had an impressive run since it went public in September. This follows a series of positive news that underpin the...

Oportun Financial Corporation (NASDAQ: OPRT) Sustains Gains Post-IPO after Strong Q3 Results

Oportun Financial Corporation (NASDAQ: OPRT) has been gaining ever since it went public. The company went public on the 26th of September at an offer...

Tela Bio Inc (NASDAQ: TELA) Sustains Positive Sentiment Post IPO

Tela Bio Inc (NASDAQ: TELA) went public on the 13th of November at an offer price of $13. The stock offer was for 4 million...

SiTime Corporation (NASDAQ: SITM) Gains Momentum Weeks after IPO

On the 25th of November SiTime Corporation (NASDAQ: SITM) announced that it had completed its IPO. The initial public offer was for 4,945,000 of the...

Cortexyme Inc (NASDAQ: CRTX) Gains Momentum as It Presents on Alzheimer’s Treatment

Like all other IPOs this year, Cortexyme Inc (NASDAQ: CRTX) has had mixed results post listing. After the initial hype, the stock collapsed, but it...

Turning Point Therapeutics (NASDAQ: TPTX) Gains Ahead Of The Piper Jaffray 31ST Annual Healthcare...

The IPO craze that was there at the beginning of the year seems to have died out. However, there are a few that continue to...

Must Read